ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1166

A Quint-Essential Diagnosis

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Malik, Mahad, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Verma, Yogesh, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Gupta, Maitreyee M., Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Gulati, Rakesh, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Martinez Cantarin, Maria P., Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Shenoy, Prashamsa, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Introduction

Febrile rash post-kidney transplant (KT) requires rapid etiologic clarification. Differential for non-blanchable papular rash (0–6 months) includes Kaposi Sarcoma (KS) or disseminated infection. Bacillary Angiomatosis (BA) is a rare mimic. Identification is critical as induction immunosuppression (IS) "opens the flood gates" for pathogens not covered by standard prophylaxis, requiring a balance between IS intensity and targeted antimicrobial therapy.

Case Description

A 62yo Afro-Haitian male received his first deceased-donor KT. Induction: anti-thymocyte globulin (2mg/kg x3). Maintenance: tacrolimus (trough 8–11ng/mL), mycophenolate 750mg BID, steroids. Prophylaxis: valganciclovir, trimethoprim-sulfamethoxazole. 4mo post-KT: fever, 13.6kg weight loss, diffuse non-blanchable rash. Labs: CMV (7,270IU/mL), BK (12,500IU/mL) viremia. CT: 2.8x1.7cm hepatic hypodensity. Biopsy suggested BA. Despite no feline/personal homelessness exposure, UNOS review revealed donor homelessness—a risk for Bartonella quintana. This enabled a "Quint-essential" diagnostic pivot. Doxycycline was started; ganciclovir maintained.

Discussion

BA mimics KS or CMV. Identifying donor risk via UNOS is vital for B. quintana, an emerging donor-derived threat. Bartonella is fastidious, failing automated cultures (requires 45-day incubation). PCR and serology are mainstays, though induction IS can blunt antibody kinetics, yielding negative early tests. Standard prophylaxis is ineffective. Evaluate for disseminated features (peliosis hepatis/osteitis) and consider Torquetenovirus (TTV) to stratify IS status.

A: Diffuse, non-blanchable maculonodular rash across the trunk, raising concern for malignancy.
B: Extremity Involvement: Multiple raised, dark-pigmented papules on the forearm.
C: Lesion Morphology: Close-up of a friable, angiomatous nodule, a hallmark of Bartonella-induced vascular proliferation.
D: Dermoscopic Detail: Magnified view highlighting the vascular architecture that prompted the biopsy.